Article

Serum neurofilament light as a biomarker for prognosis in patients with newly diagnosed Parkinson’s disease

2021-11-02

Abstract excerpt

<h4>ABSTRACT</h4> <h4>Background</h4> Patients with Parkinson’s disease (PD) have variable disease progression. More accurate prediction of progression could improve clinical trial design. Although some variance in clinical progression can be predicted by age at onset and phenotype, we hypothesise that this can be improved by blood biomarkers. <h4>Objective</h4> To determine if serum neurofilament light (NfL) is a...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: e47f59b6-d7fb-5d1b-aaf4-22db50f05719
DOI: 10.1101/2021.11.01.21265751

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Serum neurofilament light as a biomarker for prognosis in patients with newly diagnosed Parkinson’s diseaseDOI 10.1101/2021.11.01.21265751Read

Validation of Serum Neurofilament Light Chain as a Biomarker of Parkinson’s Disease ProgressionSemantic proximity Read

Increased Serum Neurofilament Light Chain Levels in Parkinson's Disease Patients Carrying the p.A53T SNCA Mutation: Data from the Parkinson's Progression Markers Initiative Study.Semantic proximity Read

Plasma NfL, clinical subtypes and motor progression in Parkinson's disease.Semantic proximity Read

Plasma neurofilament light levels show elevation prior to diagnosis of sporadic motor neuron disease in the UK Biobank cohortSemantic proximity Read

Prognostic Clinical and Biological Markers for Amyotrophic Lateral Sclerosis Disease Progression: Validation and Implications for Clinical Trial Design and AnalysisSemantic proximity Read

Longitudinal dynamics of mutant huntingtin and neurofilament light in Huntington’s disease: the prospective HD-CSF studySemantic proximity Read

Mutant huntingtin and neurofilament light have distinct longitudinal dynamics in Huntington’s diseaseSemantic proximity Read

Plasma NfL as a prognostic biomarker for enriching HD-ISS stage 1 categorisation: a cross-sectional studySemantic proximity Read

Comprehensive cross-sectional and longitudinal analyses of plasma neurofilament light across FTD spectrum disordersSemantic proximity Read

The Potential of Neurofilament Light as a Biomarker in Alzheimer’s DiseaseSemantic proximity Read

Neurofilament light protein in blood as a potential biomarker of neurodegeneration in Huntington's disease: a retrospective cohort analysisSemantic proximity Read

Tau or neurofilament light-Which is the more suitable biomarker for Huntington's disease?Semantic proximity Read